Vol. 13 (09) pp. 813-814 DOI: 10.21474/IJAR01/21765

REBUILDING HEARTS WITH CRISPR-CAS9

  • Research Scholar, Johns Hopkins Global Health Leaders Conference, Alliance Academy for Innovation.
5 Downloads 35 Views
Crossref

Download Full Paper (PDF)

Abstract

Cardiovascular disease (CVD) remains the leading global cause of mortality, responsible for nearly 17.9 million deaths annually, with a disproportionate impact on low- and middle-income countries. CRISPR-Cas9, presents unprecedented opportunities to transform cardiovascular care from reactive treatment to proactive prevention. This paper explores the applications of CRISPR-Cas9 in repairing genetic mutations linked to hypertrophic cardiomyopathy (HCM) and other heritable cardiac conditions. Studies in somatic cell editing, lipid nanoparticle delivery systems, and polygenic risk scoring, the paper highlights both the promise and limitations of gene-editingstrategies.

Keywords

Article Analytics

How to Cite This Article

Madiha Raza (2025); REBUILDING HEARTS WITH CRISPR-CAS9, Int. J. of Adv. Res., 13 (09), 813-814, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/21765

Corresponding Author

Madiha Raza
Johns Hopkins Global Health Leaders Conference
United States
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.